Some random unemployed blogger is hurling accusations at Mike Piazza. The claim: it’s a grand conspiracy that his book is going to come out after the Hall of Fame election results this winter. Because it clearly will have steroid-use admissions in it and once he’s already elected to the Hall of Fame there will be nothing anyone can do about it:
Maybe Simon & Schuster has innocently planned the Piazza publication for soon after the announcement for marketing purposes, but it might just as easily have agreed to a post-election publication to insure that the book would not keep Piazza out of the Hall.
If, on the other hand, the book includes a steroids admission, all I can say is shame on Piazza and his publisher. With that possibility in mind, though, the voters would be wise to withhold their votes from Piazza until a future election. He will have 14 more chances.
Because it’s so STRANGE for a baseball book to come out in February! I mean, apart from the fact that every single baseball book ever has been released to coincide with pitchers and catchers reporting, this smacks of sinister intent!
Oh well, Chass is gonna Chass. He’s been obliquely accusing Piazza of being a steroids user for years now, claiming res ipsa loquitur regarding Piazza back acne he once witnessed in the clubhouse. Never mind that dermatologists do not agree with Mr. Chass that back acne he witnessed is dispositive of anything.
None of which is to say that Chass is wrong about this. It’s entirely possible that Mike Piazza took steroids. It’s entirely possible that his book is going to talk about it. But if Chass is right about it he’s just guessing here. If he had something more than a hunch and a guess, he’d report it. What would stop him?
Update (8:51 PM EST): The deal is in place, according to Heyman.
Update (8:27 PM EST): Derrick Goold of the St. Louis Post-Dispatch reports that the Cardinals made an “over-the-top offer” to Fowler to ensure he’d sign.
Frank Cusumano of KSDK Sports reports that free agent outfielder will take a physical in St. Louis on Friday. Presumably, that means that Fowler and the Cardinals have gotten pretty far along in negotiations.
Jon Heyman of FanRag Sports recently reported that Fowler was looking for $18 million per year. The Blue Jays reportedly made an offer to Fowler in the four-year, $16 million range several days ago. The Cardinals’ offer to Fowler, if there is indeed one, is likely somewhere between the two figures.
Fowler, 30, is coming off of a fantastic year in which he helped the Cubs win their first World Series since 1908. During the regular season, he hit .276/.393/.447 with 13 home runs, 48 RBI, 84 runs scored, and 13 stolen bases in 551 plate appearances.
Fowler rejected the Cubs’ $17.2 million qualifying offer last month. While the QO compensation negatively affected Fowler’s experience in free agency last offseason — he didn’t sign until late February with the Cubs — his strong season is expected to make QO compensation much less of an issue.
Tommy Stokke of RanRag Sports reports that the Braves and Rangers agreed to a trade. According to ESPN’s Keith Law, the Braves will receive pitcher Luke Jackson from the Rangers in exchange for pitchers Tyrell Jenkins and Brady Feigl.
Jackson, 25, is under team control through 2022. He has logged only 18 innings in the majors, yielding 14 runs on 22 hits and eight walks with three strikeouts. While Jackson has struggled with control, the Braves likely see upside because his fastball sits in the mid- to high-90’s.
Jenkins, 24, is also under team control through 2022. The right-hander made eight starts and six relief appearances in his first major league season in 2016, putting up a 5.88 ERA with a 26/33 K/BB ratio over 52 innings.
Feigl, 25, was an undrafted free agent and was signed by the Braves in 2013. The lefty underwent Tommy John surgery in 2015 and briefly rehabbed in rookie ball this past season.